Connect with us

Hi, what are you looking for?

Law

Dallas VA malpractice lawyer-S. Greco-alerts 50% Iraqi war vets suffer PTSD!

Dallas veteran medical malpractice attorney-Greco-reveals staggering veterans injury study.

Dallas, TX (AmericanInjuryNews.com)–Indiana’s Times-Mail released the staggering results of a recent study by top Post Traumatic Stress Disorder (PTSD) psychologist revealing Iraq war worse than Vietnam war for military veterans. The study shows, according to the U.S. Department of Defense (DOD), 50% of Operation Iraqi Freedom veterans returned with PTSD as opposed to only 30 percent of Vietnam vets.

U.S. Military personnel suffering from PTSD injury need proper diagnosis and treatment for this debilitating condition. Medical specialists claim the Veterans Affairs Hospitals do not properly screen, diagnose and treat military personnel returning from the wars in Iraq and Afghanistan. Intensive therapy, proper medication and support from doctors, nurses, family members and communities is essential in rehabilitating traumatically injured vets. Hundreds of thousands of our nations veterans may not be receiving the proper care and doctors and nurses at Veterans Administration Hospitals and Clinics may be negligent in their diagnosis and treatment of PTSD.

AmericanInjuryNews.com by Dallas Veterans Affairs Lawyer Shelly T. Greco. Practice areas: Veterans Affairs Medical Malpractice Litigation.
Shelly Greco. Eberstein & Witherite, LLP. 3100 Monticello Avenue, Suite 500. Dallas, TX 75205 – Toll Free: (888) 407-6669

You May Also Like

Business

State would join dozens of others in enacting legislation based on federal government’s landmark whistleblower statute, the False Claims Act

press release

With a deep understanding of the latest tech, Erbo helps businesses flourish in a digital world.

press release

#Automotive #Carbon #Canister #Market #Projected #Hit #USD New York, US, Oct. 24, 2022 (GLOBE NEWSWIRE) —  According to a comprehensive research report by Market...

press release

Barrington Research Analyst James C.Goss reiterated an Outperform rating on shares of IMAX Corp IMAX with a Price target of $20. As theaters...